Recurrent Breast Cancer Recruiting Phase 2 Trials for Trastuzumab emtansine (DB05773)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03530696T-DM1 and Palbociclib for Metastatic HER2 Breast CancerTreatment